Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s13737-015-0029-5 http://scihub22266oqcxt.onion/10.1186/s13737-015-0029-5 C4895281!4895281 !27293552     free     free     free       Transplant+Res 2015 ; 4 (Suppl 1 ): 5 Nephropedia Template TP {{tp|p=27293552 |t=2015. Practical considerations for the use of mTOR inhibitors |pdf=|usr=}}{{27293552 }} gab.com Text Practical considerations for the use of mTOR inhibitors JO: Transplant Res http://www.kidney.de/pget.php?&tw=1&pmid=27293552 #FOAvip Immunosuppressive therapy after kidney transplantation is based on calcineurin inhibitors (CNI). In most cases CNI therapy is combined with mycophenolate and steroids. In spite of good short-term results this therapy is associated with long-term toxicities, graft loss and patient death. Therefore, alternative immunosuppressive strategies are needed that combine excellent efficacy with low incidences of long-term adverse outcomes. This review focuses on the strategies based on mTOR- inhibitors in combination with minimized exposure to CNI. Twit Text FOAVip Practical considerations for the use of mTOR inhibitors ????Transplant Res http://www.kidney.de/pget.php?&tw=1&pmid=27293552 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27293552 #FOAvip English Wikipedia <ref>{{Cite pmid|27293552 }}</ref> Practical considerations for the use of mTOR inhibitors #MMPMID27293552 Diekmann F ; Campistol JM Transplant Res 2015[]; 4 (Suppl 1 ): 5 PMID27293552 show ga Immunosuppressive therapy after kidney transplantation is based on calcineurin inhibitors (CNI). In most cases CNI therapy is combined with mycophenolate and steroids. In spite of good short-term results this therapy is associated with long-term toxicities, graft loss and patient death. Therefore, alternative immunosuppressive strategies are needed that combine excellent efficacy with low incidences of long-term adverse outcomes. This review focuses on the strategies based on mTOR- inhibitors in combination with minimized exposure to CNI. ?Practical considerations for the use of mTOR inhibitors (epmc).pdf DeepDyve Pubget Overpricing